Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter observational study of polymyxin B for febrile agranulocytosis in patients with hematological diseases
ChiCTR1900021338Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in Gram-negative bacterial infection and febrile neutropenia (FN), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Treatment success rate. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
polymyxin B
03
Conditions
Gram-negative bacterial infectionfebrile neutropenia (FN)
Beyond the preview
Go deeper on ChiCTR1900021338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021338.